Logo image of ZBRA

ZEBRA TECHNOLOGIES CORP-CL A (ZBRA) Stock Fundamental Analysis

NASDAQ:ZBRA - Nasdaq - US9892071054 - Common Stock - Currency: USD

293.06  +9.45 (+3.33%)

After market: 293.06 0 (0%)

Fundamental Rating

6

ZBRA gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 125 industry peers in the Electronic Equipment, Instruments & Components industry. While ZBRA has a great profitability rating, there are some minor concerns on its financial health. ZBRA is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

ZBRA had positive earnings in the past year.
ZBRA had a positive operating cash flow in the past year.
ZBRA had positive earnings in each of the past 5 years.
Of the past 5 years ZBRA 4 years had a positive operating cash flow.
ZBRA Yearly Net Income VS EBIT VS OCF VS FCFZBRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

1.2 Ratios

ZBRA has a Return On Assets of 6.95%. This is amongst the best in the industry. ZBRA outperforms 84.00% of its industry peers.
ZBRA has a Return On Equity of 15.14%. This is amongst the best in the industry. ZBRA outperforms 84.00% of its industry peers.
ZBRA's Return On Invested Capital of 10.78% is amongst the best of the industry. ZBRA outperforms 85.60% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ZBRA is above the industry average of 9.35%.
Industry RankSector Rank
ROA 6.95%
ROE 15.14%
ROIC 10.78%
ROA(3y)5.61%
ROA(5y)7.93%
ROE(3y)13.8%
ROE(5y)18.59%
ROIC(3y)11.59%
ROIC(5y)14.22%
ZBRA Yearly ROA, ROE, ROICZBRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

ZBRA has a better Profit Margin (10.74%) than 86.40% of its industry peers.
In the last couple of years the Profit Margin of ZBRA has declined.
ZBRA has a better Operating Margin (15.51%) than 90.40% of its industry peers.
In the last couple of years the Operating Margin of ZBRA has remained more or less at the same level.
ZBRA has a better Gross Margin (48.79%) than 84.80% of its industry peers.
In the last couple of years the Gross Margin of ZBRA has remained more or less at the same level.
Industry RankSector Rank
OM 15.51%
PM (TTM) 10.74%
GM 48.79%
OM growth 3Y-5.09%
OM growth 5Y-0.99%
PM growth 3Y-10.68%
PM growth 5Y-2.66%
GM growth 3Y1.23%
GM growth 5Y0.68%
ZBRA Yearly Profit, Operating, Gross MarginsZBRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ZBRA is creating some value.
The number of shares outstanding for ZBRA has been increased compared to 1 year ago.
The number of shares outstanding for ZBRA has been reduced compared to 5 years ago.
Compared to 1 year ago, ZBRA has an improved debt to assets ratio.
ZBRA Yearly Shares OutstandingZBRA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ZBRA Yearly Total Debt VS Total AssetsZBRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

ZBRA has an Altman-Z score of 4.06. This indicates that ZBRA is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 4.06, ZBRA is doing good in the industry, outperforming 66.40% of the companies in the same industry.
ZBRA has a debt to FCF ratio of 2.17. This is a good value and a sign of high solvency as ZBRA would need 2.17 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.17, ZBRA is in the better half of the industry, outperforming 76.80% of the companies in the same industry.
ZBRA has a Debt/Equity ratio of 0.58. This is a neutral value indicating ZBRA is somewhat dependend on debt financing.
ZBRA's Debt to Equity ratio of 0.58 is on the low side compared to the rest of the industry. ZBRA is outperformed by 76.80% of its industry peers.
Even though the debt/equity ratio score it not favorable for ZBRA, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 2.17
Altman-Z 4.06
ROIC/WACC1.31
WACC8.24%
ZBRA Yearly LT Debt VS Equity VS FCFZBRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.45 indicates that ZBRA should not have too much problems paying its short term obligations.
The Current ratio of ZBRA (1.45) is worse than 76.00% of its industry peers.
ZBRA has a Quick Ratio of 1.02. This is a normal value and indicates that ZBRA is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ZBRA (1.02) is worse than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 1.02
ZBRA Yearly Current Assets VS Current LiabilitesZBRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 68.66% over the past year.
Measured over the past 5 years, ZBRA shows a small growth in Earnings Per Share. The EPS has been growing by 0.88% on average per year.
The Revenue has grown by 17.46% in the past year. This is quite good.
Measured over the past years, ZBRA shows a small growth in Revenue. The Revenue has been growing by 2.12% on average per year.
EPS 1Y (TTM)68.66%
EPS 3Y-9.87%
EPS 5Y0.88%
EPS Q2Q%41.55%
Revenue 1Y (TTM)17.46%
Revenue growth 3Y-3.98%
Revenue growth 5Y2.12%
Sales Q2Q%11.32%

3.2 Future

Based on estimates for the next years, ZBRA will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.52% on average per year.
Based on estimates for the next years, ZBRA will show a small growth in Revenue. The Revenue will grow by 5.94% on average per year.
EPS Next Y9%
EPS Next 2Y11.3%
EPS Next 3Y11.27%
EPS Next 5Y13.52%
Revenue Next Year5.9%
Revenue Next 2Y5.99%
Revenue Next 3Y5.94%
Revenue Next 5Y5.94%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ZBRA Yearly Revenue VS EstimatesZBRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
ZBRA Yearly EPS VS EstimatesZBRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10 20 30

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 19.95, ZBRA is valued on the expensive side.
Based on the Price/Earnings ratio, ZBRA is valued a bit cheaper than 75.20% of the companies in the same industry.
ZBRA's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.57.
Based on the Price/Forward Earnings ratio of 17.51, the valuation of ZBRA can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ZBRA indicates a somewhat cheap valuation: ZBRA is cheaper than 70.40% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of ZBRA to the average of the S&P500 Index (22.41), we can say ZBRA is valued slightly cheaper.
Industry RankSector Rank
PE 19.95
Fwd PE 17.51
ZBRA Price Earnings VS Forward Price EarningsZBRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

63.20% of the companies in the same industry are more expensive than ZBRA, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ZBRA indicates a rather cheap valuation: ZBRA is cheaper than 88.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 14.89
EV/EBITDA 16.82
ZBRA Per share dataZBRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ZBRA does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of ZBRA may justify a higher PE ratio.
PEG (NY)2.22
PEG (5Y)22.63
EPS Next 2Y11.3%
EPS Next 3Y11.27%

More info and screens

0

5. Dividend

5.1 Amount

ZBRA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ZEBRA TECHNOLOGIES CORP-CL A

NASDAQ:ZBRA (6/16/2025, 8:18:20 PM)

After market: 293.06 0 (0%)

293.06

+9.45 (+3.33%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)04-29 2025-04-29/bmo
Earnings (Next)08-05 2025-08-05/bmo
Inst Owners93.22%
Inst Owner Change-0.36%
Ins Owners0.7%
Ins Owner Change3.57%
Market Cap14.90B
Analysts76.8
Price Target324.77 (10.82%)
Short Float %1.64%
Short Ratio1.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.19%
Min EPS beat(2)-0.59%
Max EPS beat(2)8.97%
EPS beat(4)3
Avg EPS beat(4)6.32%
Min EPS beat(4)-0.59%
Max EPS beat(4)11.15%
EPS beat(8)6
Avg EPS beat(8)5.43%
EPS beat(12)8
Avg EPS beat(12)3.32%
EPS beat(16)12
Avg EPS beat(16)3.86%
Revenue beat(2)0
Avg Revenue beat(2)-0.64%
Min Revenue beat(2)-0.67%
Max Revenue beat(2)-0.61%
Revenue beat(4)2
Avg Revenue beat(4)0.21%
Min Revenue beat(4)-0.67%
Max Revenue beat(4)1.13%
Revenue beat(8)4
Avg Revenue beat(8)-0.95%
Revenue beat(12)5
Avg Revenue beat(12)-1.39%
Revenue beat(16)8
Avg Revenue beat(16)-0.93%
PT rev (1m)0.87%
PT rev (3m)-19.03%
EPS NQ rev (1m)-0.49%
EPS NQ rev (3m)-7.73%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.23%
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)-0.26%
Valuation
Industry RankSector Rank
PE 19.95
Fwd PE 17.51
P/S 2.91
P/FCF 14.89
P/OCF 13.98
P/B 4.11
P/tB N/A
EV/EBITDA 16.82
EPS(TTM)14.69
EY5.01%
EPS(NY)16.74
Fwd EY5.71%
FCF(TTM)19.69
FCFY6.72%
OCF(TTM)20.96
OCFY7.15%
SpS100.57
BVpS71.31
TBVpS-14.24
PEG (NY)2.22
PEG (5Y)22.63
Profitability
Industry RankSector Rank
ROA 6.95%
ROE 15.14%
ROCE 12.55%
ROIC 10.78%
ROICexc 12.52%
ROICexgc 62.54%
OM 15.51%
PM (TTM) 10.74%
GM 48.79%
FCFM 19.57%
ROA(3y)5.61%
ROA(5y)7.93%
ROE(3y)13.8%
ROE(5y)18.59%
ROIC(3y)11.59%
ROIC(5y)14.22%
ROICexc(3y)12.35%
ROICexc(5y)15.17%
ROICexgc(3y)83.03%
ROICexgc(5y)N/A
ROCE(3y)13.49%
ROCE(5y)16.56%
ROICexcg growth 3Y-36.88%
ROICexcg growth 5Y-17.49%
ROICexc growth 3Y-16.79%
ROICexc growth 5Y-8.38%
OM growth 3Y-5.09%
OM growth 5Y-0.99%
PM growth 3Y-10.68%
PM growth 5Y-2.66%
GM growth 3Y1.23%
GM growth 5Y0.68%
F-Score8
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 2.17
Debt/EBITDA 2.18
Cap/Depr 38.24%
Cap/Sales 1.27%
Interest Coverage 19.34
Cash Conversion 110.7%
Profit Quality 182.33%
Current Ratio 1.45
Quick Ratio 1.02
Altman-Z 4.06
F-Score8
WACC8.24%
ROIC/WACC1.31
Cap/Depr(3y)40.17%
Cap/Depr(5y)39.59%
Cap/Sales(3y)1.46%
Cap/Sales(5y)1.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)68.66%
EPS 3Y-9.87%
EPS 5Y0.88%
EPS Q2Q%41.55%
EPS Next Y9%
EPS Next 2Y11.3%
EPS Next 3Y11.27%
EPS Next 5Y13.52%
Revenue 1Y (TTM)17.46%
Revenue growth 3Y-3.98%
Revenue growth 5Y2.12%
Sales Q2Q%11.32%
Revenue Next Year5.9%
Revenue Next 2Y5.99%
Revenue Next 3Y5.94%
Revenue Next 5Y5.94%
EBIT growth 1Y52.5%
EBIT growth 3Y-8.88%
EBIT growth 5Y1.11%
EBIT Next Year14.89%
EBIT Next 3Y11.07%
EBIT Next 5Y11.31%
FCF growth 1Y256.23%
FCF growth 3Y-1.88%
FCF growth 5Y8.86%
OCF growth 1Y197.77%
OCF growth 3Y-1.78%
OCF growth 5Y8.14%